PPT-“Medication Therapy Management for Patients with Diabetes

Jonathan G Marquess PharmD CDE FAPhA PresidentCEO The Institute for Wellness and Education Inc amp Multiple Independent Pharmacy Owner Woodstock Georgia Program Faculty Dr Jonathan Marquess is the President of The Institute for Wellness and Education a Disease Management Company He is owner and diabetes educator at two AADE recognized Diabetes Education Centers in Atlanta In Addition Dr Marquess and his Pharmacist wife Pam are the owners . Acute Coronary Syndromes and Diabetes. Chapter 26. Jean-Claude Tardif, Phillipe L. L’Allier,. David H. Fitchett. Acute Coronary Syndrome Checklist. SCREEN. for DM among patients with ACS. USE . anti-platelet therapies, . Working Group: . Maria E. Wolfs, MD, FRCP; . Rémi. . Rabasa-Lhoret. , MD, PhD. Canadian Cardiovascular Society Antiplatelet . Guidelines. Objectives. Interpret . the . Canadian Cardiovascular Society Guideline recommendations regarding the use of antiplatelet . Working Group: . Maria E. Wolfs, MD, FRCP; . Rémi. . Rabasa-Lhoret. , MD, PhD. Canadian Cardiovascular Society Antiplatelet . Guidelines. Objectives. Interpret . the . Canadian Cardiovascular Society Guideline recommendations regarding the use of antiplatelet . Impact on Pharmacy Practice. Kimberly Zammit, . PharmD. , BCPS, FASHP. NYS Board of Pharmacy . Chair, CDTM Implementation Committee. September 23, 2014 . Disclosures. None to report. Collaborative Drug Therapy Management. Beth Pyatak, PhD, OTR/L, CDE. Chan Division of Occupational Science and Occupational Therapy. University of Southern California. What is occupational . t. herapy (OT)?. Facilitates participation in everyday activities . Insulin Physiology. Types of Diabetes. Type I . Type 2 . Gestational Diabetes (GDM). Other specific conditions resulting in hyperglycemia. Absence of Insulin. . Hyperglycemia. Polyuria. Polydipsia. Polyphagia. Program(MTDM)-. Endless Opportunities. Michael A. Evans, B.S., RPh. Director, Ambulatory Clinical Pharmacy Programs. Co-Director, Pharmacy Outcomes Fellowship. Geisinger Health System . “Make my hospital right,. AHRQs Effective Health Care Program It is a collaborative network of research centers that support the rapid development of new scientific information and analytic tools The DEcIDE network assists hea MAHTAB NIROOMAND M.D.. Assistant professor of Endocrinology. SBUMS. Tehran 1391/11/19. . Out-line . Pathophysiology. and types of dyslipidemia in diabetic patients. Benefits of lipid- lowering therapy. In both of the common types of diabetes, environmental factors interact with genetic susceptibility to determine which people develop the clinical syndrome, and the timing of its onset.. However, the underlying genes, precipitating environmental factors and pathophysiology differ substantially between type 1 and type 2 diabetes.. is a common abnormality which usually presents with . hypogonadism. and/or . galactorrhoea. (lactation in the absence of breastfeeding). . Since prolactin stimulates milk secretion but not breast development, . 2018 ADA GUIDELINES. Dr. . Sanjana. Bhagwat. Moderator : Dr. S. . Jotkar. Diabetes is a complex, chronic illness requiring continuous medical care with multifactorial risk-reduction strategies beyond glycemic control. 116 SIGN guidelines are produced using a standard methodology that has been equality impact assessed to ensure that these equality Scottish Intercollegiate Guidelines NetworkManagement of diabetesA Pills” . New . Perspectives on Understanding and Addressing Problematic Medication Adherence. William H. Polonsky PhD, CDE. August 20, 2018. whp@behavioraldiabetes.org. DISCLOSURE TO PARTICIPANTS. Notice of Requirements For Successful Completion.